Ceribell
Brad Bachelder is an accomplished professional with extensive experience in advanced product development within the medical device industry. Currently serving as Senior Director of Advanced Product Development at Ceribell since August 2016, Bachelder played a key role in the company's upcoming IPO in 2024 and was an early employee, joining as the fourth team member. Prior to Ceribell, Bachelder held several progressive roles at ForSight VISION4, Inc., contributing to the company's focus on innovative drug delivery therapies before its acquisition by Roche. Additionally, Bachelder has a background in research and development engineering at Hantel Technologies and an early career as a software and IT intern at SwiftView, Inc. Bachelder holds a Bachelor of Science in Engineering, Product Design from Stanford University and participated in a study abroad program at the University of Canterbury.
This person is not in any teams
This person is not in any offices
Ceribell
1 followers
Ceribell is a fast growing venture-backed medical device start-up company founded by two faculty members at Stanford University. They have developed a highly innovative electroencephalography (EEG) device, which will make the diagnosis of neurological patients drastically more efficient.